INSP
insider transactionsInspire Medical Systems, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-12.3K
0 buy · 12.3K sell
Net value · 365d
-$4.2M
$0 in · $4.2M out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
13
0 buy · 12.3K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Sell·S
Title: Chief Product and Inno…
$114.3K
2.6K sh · $43.28
Own -9%
-
Sell·S
Title: Chief Product and Inno…
$30.1K
700 sh · $43.01
Own -2%
-
Sell·S
Director · 10b5-1
$31.5K
696 sh · $45.31
Own -2%
-
Other·F
Director
$2.8K
50 sh · $56.70
Own -1%
-
Grant·A
Director
$0
3.6K sh
Own +16%
-
Grant·A
Director
$0
3.6K sh
Own +16%
-
Grant·A
Director · 10b5-1
$0
3.6K sh
Own +14%
-
Grant·A
Director
$0
3.6K sh
Own +80%
-
Grant·A
Director
$0
3.6K sh
Own +106%
-
Grant·A
Director
$0
3.6K sh
Own +134%
-
Grant·A
Director
$16.0K
307 sh · $52.07
Own +7%
-
Grant·A
Director
$16.0K
308 sh · $52.07
Own +1%
-
Exercise·M
EVP & Chief Medical Officer · 10b5-1
$0
105 sh
Own +10%
-
Sell·S
EVP & Chief Medical Officer · 10b5-1
$51.9K
105 sh · $493.95
Own -100%
-
Exercise·M
EVP & Chief Medical Officer · 10b5-1
$24.1K
105 sh · $229.39
Own New
-
Sell·S
EVP & Chief Medical Officer · 10b5-1
$2.3M
4.7K sh · $487.18
Own -92%
-
Exercise·M
EVP & Chief Medical Officer · 10b5-1
$0
125 sh
Own New
-
Sell·S
EVP & Chief Medical Officer · 10b5-1
$61.6K
125 sh · $492.59
Own -2%
-
Exercise·M
EVP & Chief Medical Officer · 10b5-1
$26.1K
125 sh · $208.90
Own +2%
-
Exercise·M
EVP & Chief Medical Officer · 10b5-1
$0
1.0K sh
Own New
-
Exercise·M
EVP & Chief Medical Officer · 10b5-1
$0
8.4K sh
Own New
-
Other·F
EVP & Chief Medical Officer · 10b5-1
$2.1M
4.2K sh · $503.51
Own -45%
-
Exercise·M
EVP & Chief Medical Officer · 10b5-1
$0
8.4K sh
Own +917%
-
Other·F
EVP & Chief Medical Officer · 10b5-1
$250.2K
497 sh · $503.51
Own -35%
-
Exercise·M
EVP & Chief Medical Officer · 10b5-1
$0
1.0K sh
Own +245%
-
Sell·S
EVP & Chief Medical Officer · 10b5-1
$1.2M
2.3K sh · $499.71
Own -85%
-
Exercise·M
EVP & Chief Medical Officer
$0
1.6K sh
Own New
-
Exercise·M
EVP & Chief Medical Officer
$0
3.1K sh
Own +305200%
-
Grant·A
EVP & Chief Medical Officer
$0
2.8K sh
Own +50%
-
Other·F
EVP & Chief Medical Officer
$402.4K
795 sh · $506.17
Own -22%
-
Exercise·M
EVP & Chief Medical Officer
$0
1.6K sh
Own +82%
-
Other·F
EVP & Chief Medical Officer
$766.3K
1.5K sh · $506.17
Own -44%
-
Exercise·M
EVP & Chief Medical Officer
$0
3.1K sh
Own +746%
-
Grant·A
Bryan K Phillips KEY
Senior Vice President, Genera…
$0
8.4K sh
Own +28%
-
Grant·A
Bryan K Phillips KEY
Senior Vice President, Genera…
$0
16.0K sh
Own +113%
-
Other·F
Bryan K Phillips KEY
Senior Vice President, Genera…
$43.8K
735 sh · $59.53
Own -5%
-
Grant·A
Bryan K Phillips KEY
Senior Vice President, Genera…
$0
2.4K sh
Own +19%
-
Grant·A
Title - Chief Manufacturing a…
$0
16.0K sh
Own +400%
-
Grant·A
Chief People Officer
$0
16.0K sh
Own +209%
-
Grant·A
Chief Strategy and Growth Off…
$0
12.6K sh
Own +43%
-
Grant·A
Chief Strategy and Growth Off…
$0
21.0K sh
Own +260%
-
Other·F
Chief Strategy and Growth Off…
$40.0K
672 sh · $59.53
Own -8%
-
Grant·A
Chief Strategy and Growth Off…
$0
2.2K sh
Own +33%
-
Grant·A
Title: Chief Product and Inno…
$0
16.0K sh
Own +110%
-
Other·F
Title: Chief Product and Inno…
$43.8K
735 sh · $59.53
Own -5%
-
Grant·A
Title: Chief Product and Inno…
$0
2.4K sh
Own +19%
-
Grant·A
CEO and President
$0
62.2K sh
Own +165%
-
Other·F
CEO and President
$238.7K
4.0K sh · $59.53
Own -10%
-
Grant·A
CEO and President
$0
9.0K sh
Own +28%
-
Other·F
Chief People Officer
$36.8K
615 sh · $59.76
Own -7%
-
Other·F
Title: Chief Product and Inno…
$35.1K
587 sh · $59.76
Own -4%
-
Other·F
Title - Chief Manufacturing a…
$32.9K
551 sh · $59.76
Own -12%
-
Other·F
Chief Strategy and Growth Off…
$34.1K
570 sh · $59.76
Own -8%
-
Other·F
Bryan K Phillips KEY
Senior Vice President, Genera…
$34.6K
579 sh · $59.76
Own -4%
-
Other·F
CEO and President
$97.7K
1.6K sh · $59.76
Own -5%
-
Sell·S
EVP & Chief Medical Officer · 10b5-1
$208.4K
421 sh · $494.96
Own -51%
-
Exercise·M
EVP & Chief Medical Officer · 10b5-1
$0
838 sh
Own New
-
Exercise·M
EVP & Chief Medical Officer · 10b5-1
$0
105 sh
Own +9%
-
Sell·S
EVP & Chief Medical Officer · 10b5-1
$51.9K
105 sh · $494.65
Own -11%
-
Exercise·M
EVP & Chief Medical Officer · 10b5-1
$24.1K
105 sh · $229.39
Own +13%
-
Other·F
EVP & Chief Medical Officer · 10b5-1
$205.5K
417 sh · $492.84
Own -33%
-
Exercise·M
EVP & Chief Medical Officer · 10b5-1
$0
838 sh
Own +205%
-
Other·F
Chief Strategy and Growth Off…
$21.7K
327 sh · $66.33
Own -4%
-
Other·F
Bryan K Phillips KEY
Senior Vice President, Genera…
$21.7K
327 sh · $66.33
Own -2%
-
Other·F
Title: Chief Product and Inno…
$21.7K
327 sh · $66.33
Own -2%
-
Other·F
CEO and President
$64.2K
968 sh · $66.33
Own -3%
-
Exercise·M
EVP & Chief Medical Officer · 10b5-1
$0
126 sh
Own New
-
Sell·S
EVP & Chief Medical Officer · 10b5-1
$65.5K
126 sh · $520.02
Own -100%
-
Exercise·M
EVP & Chief Medical Officer · 10b5-1
$26.3K
126 sh · $208.90
Own New
-
Grant·A
EVP & Chief Medical Officer · 10b5-1
$0
5.6K sh
Own New
-
Exercise·M
EVP & Chief Medical Officer · 10b5-1
$0
105 sh
Own +8%
-
Exercise·M
EVP & Chief Medical Officer · 10b5-1
$0
125 sh
Own +99%
-
Sell·S
EVP & Chief Medical Officer · 10b5-1
$66.6K
125 sh · $532.61
Own -100%
-
Exercise·M
EVP & Chief Medical Officer · 10b5-1
$26.1K
125 sh · $208.90
Own New
-
Sell·S
EVP & Chief Medical Officer · 10b5-1
$55.9K
105 sh · $532.61
Own -100%
-
Exercise·M
EVP & Chief Medical Officer · 10b5-1
$24.1K
105 sh · $229.39
Own New
-
Grant·A
Director
$17.4K
180 sh · $96.47
Own +5%
-
Grant·A
Director
$17.5K
181 sh · $96.47
Own +1%
-
Sell·S
Title: Chief Product and Inno… · 10b5-1
$10.9K
109 sh · $100.00
Own -1%
-
Grant·A
Director
$0
46.9K sh
Own +14%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 15, 2026 | John Rondoni | Sell S | 2.6K | $114.3K |
| May 14, 2026 | John Rondoni | Sell S | 700 | $30.1K |
| May 8, 2026 | Shawn Mccormick 10b5-1 | Sell S | 696 | $31.5K |
| May 1, 2026 | Georgia Melenikiotou | Other F | 50 | $2.8K |
| Apr 30, 2026 | Dana G Mead Jr. | Grant A | 3.6K | $0 |
| Apr 30, 2026 | Casey M Tansey | Grant A | 3.6K | $0 |
| Apr 30, 2026 | Shawn Mccormick 10b5-1 | Grant A | 3.6K | $0 |
| Apr 30, 2026 | Georgia Melenikiotou | Grant A | 3.6K | $0 |
| Apr 30, 2026 | Curet Myriam | Grant A | 3.6K | $0 |
| Apr 30, 2026 | Cynthia Burks | Grant A | 3.6K | $0 |
| Apr 15, 2026 | Georgia Melenikiotou | Grant A | 307 | $16.0K |
| Apr 15, 2026 | Casey M Tansey | Grant A | 308 | $16.0K |
| Mar 10, 2026 | Curet Myriam 10b5-1 | Exercise M | 105 | $0 |
| Mar 10, 2026 | Curet Myriam 10b5-1 | Sell S | 105 | $51.9K |
| Mar 10, 2026 | Curet Myriam 10b5-1 | Exercise M | 105 | $24.1K |
| Mar 3, 2026 | Curet Myriam 10b5-1 | Sell S | 4.7K | $2.3M |
| Mar 2, 2026 | Curet Myriam 10b5-1 | Exercise M | 125 | $0 |
| Mar 2, 2026 | Curet Myriam 10b5-1 | Sell S | 125 | $61.6K |
| Mar 2, 2026 | Curet Myriam 10b5-1 | Exercise M | 125 | $26.1K |
| Feb 28, 2026 | Curet Myriam 10b5-1 | Exercise M | 1.0K | $0 |
| Feb 28, 2026 | Curet Myriam 10b5-1 | Exercise M | 8.4K | $0 |
| Feb 28, 2026 | Curet Myriam 10b5-1 | Other F | 4.2K | $2.1M |
| Feb 28, 2026 | Curet Myriam 10b5-1 | Exercise M | 8.4K | $0 |
| Feb 28, 2026 | Curet Myriam 10b5-1 | Other F | 497 | $250.2K |
| Feb 28, 2026 | Curet Myriam 10b5-1 | Exercise M | 1.0K | $0 |
| Feb 27, 2026 | Curet Myriam 10b5-1 | Sell S | 2.3K | $1.2M |
| Feb 26, 2026 | Curet Myriam | Exercise M | 1.6K | $0 |
| Feb 26, 2026 | Curet Myriam | Exercise M | 3.1K | $0 |
| Feb 26, 2026 | Curet Myriam | Grant A | 2.8K | $0 |
| Feb 26, 2026 | Curet Myriam | Other F | 795 | $402.4K |
| Feb 26, 2026 | Curet Myriam | Exercise M | 1.6K | $0 |
| Feb 26, 2026 | Curet Myriam | Other F | 1.5K | $766.3K |
| Feb 26, 2026 | Curet Myriam | Exercise M | 3.1K | $0 |
| Feb 20, 2026 | Bryan K Phillips KEY | Grant A | 8.4K | $0 |
| Feb 20, 2026 | Bryan K Phillips KEY | Grant A | 16.0K | $0 |
| Feb 20, 2026 | Bryan K Phillips KEY | Other F | 735 | $43.8K |
| Feb 20, 2026 | Bryan K Phillips KEY | Grant A | 2.4K | $0 |
| Feb 20, 2026 | Jason P Kelly | Grant A | 16.0K | $0 |
| Feb 20, 2026 | Melissa Mann | Grant A | 16.0K | $0 |
| Feb 20, 2026 | Carlton Weatherby | Grant A | 12.6K | $0 |
| Feb 20, 2026 | Carlton Weatherby | Grant A | 21.0K | $0 |
| Feb 20, 2026 | Carlton Weatherby | Other F | 672 | $40.0K |
| Feb 20, 2026 | Carlton Weatherby | Grant A | 2.2K | $0 |
| Feb 20, 2026 | John Rondoni | Grant A | 16.0K | $0 |
| Feb 20, 2026 | John Rondoni | Other F | 735 | $43.8K |
| Feb 20, 2026 | John Rondoni | Grant A | 2.4K | $0 |
| Feb 20, 2026 | Timothy P. Herbert KEY | Grant A | 62.2K | $0 |
| Feb 20, 2026 | Timothy P. Herbert KEY | Other F | 4.0K | $238.7K |
| Feb 20, 2026 | Timothy P. Herbert KEY | Grant A | 9.0K | $0 |
| Feb 13, 2026 | Melissa Mann | Other F | 615 | $36.8K |
| Feb 13, 2026 | John Rondoni | Other F | 587 | $35.1K |
| Feb 13, 2026 | Jason P Kelly | Other F | 551 | $32.9K |
| Feb 13, 2026 | Carlton Weatherby | Other F | 570 | $34.1K |
| Feb 13, 2026 | Bryan K Phillips KEY | Other F | 579 | $34.6K |
| Feb 13, 2026 | Timothy P. Herbert KEY | Other F | 1.6K | $97.7K |
| Feb 11, 2026 | Curet Myriam 10b5-1 | Sell S | 421 | $208.4K |
| Feb 10, 2026 | Curet Myriam 10b5-1 | Exercise M | 838 | $0 |
| Feb 10, 2026 | Curet Myriam 10b5-1 | Exercise M | 105 | $0 |
| Feb 10, 2026 | Curet Myriam 10b5-1 | Sell S | 105 | $51.9K |
| Feb 10, 2026 | Curet Myriam 10b5-1 | Exercise M | 105 | $24.1K |
| Feb 10, 2026 | Curet Myriam 10b5-1 | Other F | 417 | $205.5K |
| Feb 10, 2026 | Curet Myriam 10b5-1 | Exercise M | 838 | $0 |
| Feb 9, 2026 | Carlton Weatherby | Other F | 327 | $21.7K |
| Feb 9, 2026 | Bryan K Phillips KEY | Other F | 327 | $21.7K |
| Feb 9, 2026 | John Rondoni | Other F | 327 | $21.7K |
| Feb 9, 2026 | Timothy P. Herbert KEY | Other F | 968 | $64.2K |
| Jan 29, 2026 | Curet Myriam 10b5-1 | Exercise M | 126 | $0 |
| Jan 29, 2026 | Curet Myriam 10b5-1 | Sell S | 126 | $65.5K |
| Jan 29, 2026 | Curet Myriam 10b5-1 | Exercise M | 126 | $26.3K |
| Jan 28, 2026 | Curet Myriam 10b5-1 | Grant A | 5.6K | $0 |
| Jan 27, 2026 | Curet Myriam 10b5-1 | Exercise M | 105 | $0 |
| Jan 27, 2026 | Curet Myriam 10b5-1 | Exercise M | 125 | $0 |
| Jan 27, 2026 | Curet Myriam 10b5-1 | Sell S | 125 | $66.6K |
| Jan 27, 2026 | Curet Myriam 10b5-1 | Exercise M | 125 | $26.1K |
| Jan 27, 2026 | Curet Myriam 10b5-1 | Sell S | 105 | $55.9K |
| Jan 27, 2026 | Curet Myriam 10b5-1 | Exercise M | 105 | $24.1K |
| Jan 15, 2026 | Georgia Melenikiotou | Grant A | 180 | $17.4K |
| Jan 15, 2026 | Casey M Tansey | Grant A | 181 | $17.5K |
| Jan 9, 2026 | John Rondoni 10b5-1 | Sell S | 109 | $10.9K |
| Jan 2, 2026 | Curet Myriam | Grant A | 46.9K | $0 |
About INSP insider trading
This page tracks insider transactions for Inspire Medical Systems, Inc. (INSP) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.